Won Ki Kang

Xinjiang Medical University — China

Medicine · Health Sciences

71h-index25.2kcitations637works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(271), Gastrointestinal Tumor Research and Treatment(140), Colorectal Cancer Treatments and Studies(130), Cancer Immunotherapy and Biomarkers(69), Helicobacter pylori-related gastroenterology studies(63)

Publications637 total

Modified Steel Probe Technique for Retrieving Fractured Burs in Third Molar Surgery: A Case Series
2025Open Access
Neoadjuvant CTLA-4/PD-(L)1 Blockade Versus Surgery +/− Chemotherapy in Deficient Mismatch Repair/Microsatellite Instability–High Resectable Gastroesophageal Adenocarcinoma: Individual Patient Data Pooled Analysis
Journal of Clinical Oncology·2025· 2 cited
Knowledge and practice gaps in the emergency management practices of children with dental trauma: a cross-sectional survey among primary school health teachers and parents in Urumqi
BMC Oral Health·2025· 1 citedOpen Access
Comprehensive analysis of <i>KRAS</i> aberrations in pan-cancer, with a focus on prognostic and therapeutic implications
Therapeutic Advances in Medical Oncology·2025Open Access
Nivolumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4)
Cancer Research and Treatment·2025· 2 citedOpen Access
Knowledge Gaps and Emergency Management Practices of Children’s Dental Trauma: A Cross-Sectional Survey Among Primary School Health Teachers and Parents in Urumqi
2025Open Access
Individual patient data (IPD) pooled analysis on the optimal therapeutic management of patients with microsatellite instability-high (MSI) resectable gastroesophageal adenocarcinoma (GEA).
Journal of Clinical Oncology·2025· 1 cited
277P Nivolumab (NIVO) plus gemcitabine-cisplatin (GC) vs GC alone for previously untreated unresectable or metastatic urothelial carcinoma (u/mUC): Chinese population analysis results from the phase III CheckMate 901 trial
Annals of Oncology·2024Open Access
Abstract A010: Tumor-reactive T cell clonal dynamics across treatment time points drive resistance and progression to frontline chemoimmunotherapy in advanced gastric cancer
Cancer Immunology Research·2024
The Impact of Pembrolizumab as a Salvage Therapy Based on HER2 Expression in Advanced Gastric Cancer
Cancers·2024Open Access
Efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer according to programmed cell death ligand 1
World Journal of Gastrointestinal Oncology·2024· 3 citedOpen Access
Clinical outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision in locally advanced rectal cancer with mesorectal fascia involvement
Radiation Oncology Journal·2024· 2 citedOpen Access
Figure S8 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024Open Access
Figure S27 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024Open Access
Figure S5 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024Open Access
Figure S2 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024Open Access
Data from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024· 2 citedOpen Access
Figure S3 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024Open Access
Figure S20 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024Open Access
Figure S2 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024Open Access
page 1 of 32Next →

Frequent Co-authors

Jeeyun Lee(25), Joon Oh Park(24), Ho Yeong Lim(20), Se Hoon Park(18), Young Suk Park(14), Kyoung‐Mee Kim(13), Tae Sung Sohn(12), Yoon‐Koo Kang(10), Seung Tae Kim(10), Jae Moon Bae(8), Keunchil Park(8), Hyun Cheol Chung(7), Min Gew Choi(7), Yong‐Seok Jee(7), Kihyun Kım(7), Narikazu Boku(6), Sang Cheul Oh(6), Sung Kim(6), Young Suk Park(6), Min‐Hee Ryu(5)